Q3 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch
The third quarter brought new pharmacy developments for plan sponsors to watch, including approvals in COVID-19 prevention, cholesterol management, ADHD […]
PBM Contract Red Flags: Definitions, Guarantees and Rebate Terms
By Beckie Fenrick, PharmD, MBA, Chief Pharmacy Officer, Navion A PBM proposal often arrives looking reassuringly precise. The discounts run
Moving From Fully Insured to Self-Funded? Start With Pharmacy
On Point with Navion, Episode 1 When an employer considers moving from a fully insured health plan to self-funding, much
2026 Childhood Vaccine Schedule Updates: What’s in Effect and What Could Change
By Jason Peterson, RPh; Beckie Fenrick, PharmD; and Long Tran, PharmD As families prepare for a new school year, immunization records are back
Biosimilars: Is Your Plan Capturing the Value?
By Beckie Fenrick, PharmD, MBA, Chief Pharmacy Officer at Navion Every major PBM has biosimilars on formulary. That doesn’t mean your groups are saving
Your Groups Are Overpaying on Pharmacy. The Renewal Math Is Hiding It.
By Lad Williamson, Vice President of Business Development at Navion Every year, the same meeting happens. The renewal comes in higher than
Migraine Medications and Rising Pharmacy Spend: What Plan Sponsors Need to Know
By Long Tran, PharmD; Beckie Fenrick, PharmD; and Jason Peterson, RPh Migraine treatment has changed significantly over the past decade. What
